Volume 33, Issue 1, March 2022

Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2021;32(4):345-9
Prognostic Role of Measurement of Renal Resistive Index in Systemic Sclerosis
Authors Information

1. Clinical Immunology and Rheumatology Division Postgraduate Institute of Medical Education and Research, Chandigarh, India
2. Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
3. Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
4. Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, India

  1. Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum;1975;4:351-68.
  2. Platt JF, Ellis JH, Rubin JM, DiPietro MA, Sedman AB. Intrarenal arterial Doppler ultrasonography in patients with non-obstructive renal disease: Correlation of resistive index with biopsy findings. AJR Am J Roentgenol 1990;154:1223-27.
  3. Rivolta R, Mascagni B, Berruti V, Quarto Di Palo F, Elli A, Scorza R, et al. Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy. Arthritis Rheum 1996;39:1030-4.
  4. Rosato E, Gigante A, Barbano B, Cianci R, Molinaro I, Rossi C, et al. Intrarenal hemodynamic parameters correlate with glomerular filtration rate and digital microvascular damage in patients with systemic sclerosis. Semin Arthritis Rheum 2012;41:815-21.
  5. Rosato E, Barbano B, Gigante A,Molinaro I, Quarta S, Pisarri S, et al. Increased Intrarenal Arterial Stiffness May Predict the Occurrence of New Digital Ulcers in Systemic Sclerosis. Arthritis Care Res 2014;66:1380-5.
  6. Rosato E, Gigante A, Barbano B, Gasperini ML, Cianci R, Muscaritoli M. Prognostic Factors of Renal Involvement in Systemic Sclerosis. Kidney Blood Press Res 2018;43:682-9.
  7. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-47.
  8. Tublin ME, Bude RO, Platt JF. The resistive index in renal Doppler sonography: where do we stand? Am J Roentgenol 2003;180:885-92.
  9. Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, et al.Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis 2019;78:879-89.
  10. Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, et al. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med 2010;182:252-60.
  11. Launay D, Sobanski V, Hachulla E, Humbert M. Pulmonary hypertension in systemic sclerosis: different phenotypes. Eur Respir Rev 2017;26 (145).
  12. Howard LS, Grapsa J, Dawson D, Bellamy M, Chambers JB, Masani ND, et al. Echocardiographic assessment of pulmonary hypertension: standard operating procedure. Eur Respir Rev 2012;125:239-48. 
  13. Leodori G, Pellicano C, Gigante A, Rosato E. Estimated glomerular filtration rate and renal resistive index as possible predictive markers of mortality in systemic sclerosis. Eur J Intern Med 2021 May;87:83-9.
  14.  Shanmugam VK, Steen VD. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management. Curr Opin Rheumatol 2012;24:669-76.
  15. Seiberlich B, Hunzelmann N, Krieg T, Weber M, Schulze-Lohoff E. Intermediate molecular weight proteinuria and albuminuria identify scleroderma patients with increased morbidity, Clin Nephrol 2008;70:110-17.
  16. Gupta R, Bammigatti C, Dinda AK, Marwaha V, Gupta S. Prevalence of renal involvement in indian patient with systemic sclerosis. Indian J Med Sci 2007;61:91-6.
  17. Gigante A, Bruni C, Lepri G, Tesei G, Maestripieri V, Guiducci S, et al.  The Renal Resistive Index: A New Biomarker for the Follow-up of Vascular Modifications in Systemic Sclerosis. J Rheumatol 2021 Feb;48(2):241-6.